Tilmanocept

DB15373ApprovedInvestigationalWithdrawnSmall molecule

Tilmanocept is under investigation in clinical trial NCT03241446 (Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis...

Mechanism: Pharmacologically active on Macrophage mannose receptor 1
Curator reviewed

Resolves to

Compound

UNIIMDU8BQ474HCAS1185986-76-8

Targets

P22897MRC1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

29Clinical trialsPhase, status and sponsor resolved per trial

5Structured indicationsCondition, population, route and combination as fields, not prose

4Marketed productsAcross 2 countries and 1 labeller

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tilmanocept, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account